5 Spectacular AI Stocks to Buy Now and Hold For the Long Term

Please review some cannabis plays when you can

AI Veritone up 218% YTD

Bought PLTR recently. Only thing that bothers me is it is also part of ARK investments 😅...

Hi Neil. Good video as always. Hey, quick question: What do you think of Broadcom? (disclaimer: I own Broadcom, it is probably my largest position considering how much it ran). It's a great AI stock, it's a diversified business (both semiconductor as well as software). What are your thoughts on this stock? I think it's the 3rd best performer in the stock market in last few yrs.

Don't get sick of talking about AI. Its the hot money maker. Ride it till the wheels fall off. I would be interested in your take on the weed stocks jumping up. Guess its because Germany legalized but if im correct, that ride's wheels fell off a while ago..

Viking Therapeutic up 800% in 12 months.. $8 Billion market cap.. Drug has yet to be approved.. buy out rumours..

Altimmune ($477 million cap) said its experimental drug in a midstage trial helped patients shed weight but also minimized the loss of muscle mass.

Altimmune is one of several smaller biotech companies pushing to compete with Novo Nordisk and Eli Lilly in the growing weight loss drug space.

The results are an early sign that the biotech company can address a big area of concern around those treatments, which is that they shrink the critical muscle mass that helps prevent injuries.

Some health experts have said that obesity drugs could shrink critical muscle mass, which could raise the risk of injuries and decrease strength.

But in Altimmune’s late stage trial, more than 74% of the weight that patients lost after taking the company’s weekly injection came from fat tissue and only 25% came from lean mass, according to the company. Those results are similar to those often seen with diet and exercise programs for weight loss.

Tilray has perked up.. 🤫

Sava tempting to perk up.. 🤫🤫

Yellen warns China’s surplus of solar panels, EVs could be dumped on global markets.. 🤔

Hi coach, looking forward for your opinion, investing in ETF with high expenses, still high dividend.. let’s say expense: 1% and Dividend 9% .. let’s suppose also it’s not volatile, limited either up or down.. what should I expect? Thanks

Yep, have most of those, except META and MSFT. Wish I'd added META when you were covering it last year. May yet get one of them if there's a big pull back in either.

Can you take a look at some MJ stocks? Legalization might be coming

@Couchinvestor, your 100k portfolio has mostly long plays and not any anchor positions AKA Nvidia, Microsoft, Meta; the forward growth acceleration of forward pe is more important than just the forward pe.

You like any cannabis stocks right now?

NVDA AMZN GOOGL MSFT PLTR

Rumble's financial achievements in 2023 include a remarkable 106% increase in annual revenue, which reached $81.0 million. This growth reflects the platform's expanding user base and the successful launch of Rumble Cloud, a major milestone for the company. However, the company also faced challenges, with a significant increase in costs of services, primarily due to programming and content costs, which rose by 68% to $39.5 million in the fourth quarter. This has contributed to a net loss of $29.3 million for the same period… 🤔

This was a great video. Can you do a similar video for small or mid cap AI stocks? 🙏🙏🙏

Wow, you discover the hot water

Yo u guys keep asking the man about weed stocks like this is a domino effect lmao!!! One person asks about weed stocks and then 50 others. Potheads study weed stocks